Latest news
Forlong Biotechnology Announces Successful Completion of GMP Pivotal Batch Production for FL115 (IL-15 Superagonist), Ready to Support Upcoming Phase III Clinical Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) - Business WireBusiness Wire · Mon, 03 Aug 2026 12:00:00 GMTAllvia Names Industry Veterans Chris Michalak and Larry Dunivan as Independent Directors - Business WireBusiness Wire · Tue, 28 Jul 2026 07:00:00 GMT